Posts Tagged ‘Janne Larsson’

Public reports reveal psychiatric drugs linked to 64% of all suicides in Sweden

Tuesday, June 29th, 2010

Public reports reveal psychiatric drugs linked to 64% of all suicides in Sweden

The One Click Group
By Janne Larsson
June 29, 2010

This unique report presents data about the preceding psychiatric drug treatment for all persons who committed suicide in Sweden 2007. The conclusion is that a large percentage of the persons who committed suicide had received extensive treatment with psychiatric drugs within a year of and close to the suicide.
Public reports reveal psychiatric drugs linked to 64% of all suicides in Sweden.

This is a report about suicides committed in Sweden (with around 9 million citizens) in 2007 and the psychiatric drug treatment that preceded these suicides.

The report has three main parts:

• It gives unique data about all suicides committed in 2007 and the psychiatric drugs that the persons received within a year of the suicide.

• It compares these data with autopsy reports about psychiatric drugs found in the blood (of 98%) of all the persons who committed suicide in 2007.

• It gives extensive information about the psychiatric drug treatment given within a year to the subgroup of persons who committed suicide in 2007 and then were reported to the National Board of Health and Welfare by reason of law 3 – one third of all suicides committed that year.

The data presented on these pages should have been published by the responsible national authorities.

A large percentage of the persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of their suicide.

The idea that persons who are depressed are suffering from “chemical imbalances” and are deficient in the substance serotonin has been marketed by the pharmaceutical companies selling antidepressants (in the class of antidepressant drugs called Selective Serotonin Reuptake Inhibitors, SSRIs, such as Prozac, Paxil/Seroxat, Zoloft) for more than a decade. The intensive marketing has led persons to believe that their low mood is a deficiency disease – and that it is vital to supply the substance that corrects this deficiency – the antidepressant drug.

But there is no scientific evidence that a low mood is caused by a ”chemical imbalance” in the brain. The hypothesis has been rejected with the following words by one of the most well known names in the field, Dr. David Healy,“The serotonin theory of depression is comparable to the masturbatory theory of insanity.”

The Swedish medical agencies and their psychiatric consultants have used old data from forensic toxicological screenings to mislead the public and to heavily increase the use of antidepressants and other psychiatric drugs.

The most important information in this area is the patients’ medical history; the treatment history. Antidepressants, neuroleptics and other psychiatric drugs may cause harmful changes in the brain and these brain dysfunctions do not vanish when the drugs are discontinued – in many cases they cause chronic dysfunction to the brain, exemplified by the known neurological harm caused by neuroleptics. Many patients also get serious withdrawal reactions; reactions that can be so severe that they can lead to suicide.

Better sources of information are the unpublished clinical trials of psychiatric drugs done by pharmaceutical companies, and the important studies done by independent researchers. A number of these studies show that antidepressants and neuroleptics increase the risk of suicidal behaviour and directly cause effects that lead to suicide.

Download and read the full report here; http://www.theoneclickgroup.co.uk/documents/ME-CFS_docs/Psychiatric%20Drugs%20&%20Suicide,%20Sweden%202007.pdf

« Return to news items


Share

Confidential report reveals: Big Pharma trying to stop long-term safety studies of ADHD drugs

Friday, March 5th, 2010

TransWorldNews
By Janne Larsson
March 5, 2010

The companies producing methylphenidate products (like Ritalin and Concerta) are normally competitors, marketing ADHD as a disease and the narcotic drugs as its solution. But when they are threatened with marketing restrictions they have a common interest.

If more scientific long-term studies would be done showing the harmful effects of the drugs it could lead to withdrawal from the market of this class of drugs. Therefore Big Pharma has to stop all such studies not written and controlled by themselves. The only studies they support are those conducted by paid researchers like psychiatry professors Joseph Biederman, Timothy Wilens and Thomas Spencer, where the outcome is known already from the beginning.

The European Commission has 27 May 2009, after a long review by the European Medicines Agency (EMEA), decided to issue warnings about methylphenidate drugs. The Commission has also decided that a number of long-term studies of good quality should be done to investigate different harmful effects of these drugs.

So for example the manufacturers were ordered to submit data how they could do long-term studies of psychiatric adverse effects (e.g. depression, hostility and psychotic reactions) and of cognitive effects (effects on learning, intellectual function) of the drugs. The answer from the pharmaceutical companies was a confidential report Feasibility Assessment of a Study of Long-term Effects of Methylphenidate on Cognition and Psychiatric Outcomes written 30 October 2009 – now made public by a Swedish court.

Read entire article:  http://www.transworldnews.com/NewsStory.aspx?StoryID=244733

« Return to news items


Share